- Home
- MGRM vs CRBU Comparison
MGRM vs CRBU Comparison
Compare MGRM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- CRBU
- Stock Information
- Founded
- MGRM 2016
- CRBU 2011
- Country
- MGRM United States
- CRBU United States
- Employees
- MGRM N/A
- CRBU N/A
- Industry
- MGRM Medical/Dental Instruments
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- MGRM Health Care
- CRBU Health Care
- Exchange
- MGRM Nasdaq
- CRBU Nasdaq
- Market Cap
- MGRM 79.9M
- CRBU 93.0M
- IPO Year
- MGRM N/A
- CRBU 2021
- Fundamental
- Price
- MGRM $2.41
- CRBU $1.06
- Analyst Decision
- MGRM Strong Buy
- CRBU Strong Buy
- Analyst Count
- MGRM 1
- CRBU 4
- Target Price
- MGRM $5.40
- CRBU $8.50
- AVG Volume (30 Days)
- MGRM 69.5K
- CRBU 943.1K
- Earning Date
- MGRM 05-14-2025
- CRBU 05-08-2025
- Dividend Yield
- MGRM N/A
- CRBU N/A
- EPS Growth
- MGRM N/A
- CRBU N/A
- EPS
- MGRM N/A
- CRBU N/A
- Revenue
- MGRM N/A
- CRBU $9,918,000.00
- Revenue This Year
- MGRM N/A
- CRBU N/A
- Revenue Next Year
- MGRM N/A
- CRBU $161.81
- P/E Ratio
- MGRM N/A
- CRBU N/A
- Revenue Growth
- MGRM N/A
- CRBU N/A
- 52 Week Low
- MGRM $1.92
- CRBU $0.66
- 52 Week High
- MGRM $4.21
- CRBU $3.00
- Technical
- Relative Strength Index (RSI)
- MGRM 38.50
- CRBU 56.92
- Support Level
- MGRM $2.54
- CRBU $0.98
- Resistance Level
- MGRM $2.69
- CRBU $1.21
- Average True Range (ATR)
- MGRM 0.19
- CRBU 0.10
- MACD
- MGRM -0.02
- CRBU 0.02
- Stochastic Oscillator
- MGRM 13.79
- CRBU 65.99
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.